{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,12]],"date-time":"2025-10-12T19:44:43Z","timestamp":1760298283190},"reference-count":37,"publisher":"Springer Science and Business Media LLC","issue":"12","license":[{"start":{"date-parts":[[2010,9,8]],"date-time":"2010-09-08T00:00:00Z","timestamp":1283904000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Cancer Immunol Immunother"],"published-print":{"date-parts":[[2010,12]]},"DOI":"10.1007\/s00262-010-0906-1","type":"journal-article","created":{"date-parts":[[2010,9,7]],"date-time":"2010-09-07T11:00:01Z","timestamp":1283857201000},"page":"1801-1811","source":"Crossref","is-referenced-by-count":14,"title":["Analysis of a cholera toxin B subunit (CTB) and human mucin 1 (MUC1) conjugate protein in a MUC1-tolerant mouse model"],"prefix":"10.1007","volume":"59","author":[{"given":"Julia","family":"Pinkhasov","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M. Lucrecia","family":"Alvarez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Latha B.","family":"Pathangey","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Teresa L.","family":"Tinder","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hugh S.","family":"Mason","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Amanda M.","family":"Walmsley","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sandra J.","family":"Gendler","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Pinku","family":"Mukherjee","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2010,9,8]]},"reference":[{"key":"906_CR1","first-page":"1437","volume":"53","author":"R Dahiya","year":"1993","unstructured":"Dahiya R, Kwak KS, Byrd JC, Ho S, Yoon WH, Kim YS (1993) Mucin synthesis and secretion in various human epithelial cancer cell lines that express the MUC-1 mucin gene. Cancer Res 53:1437\u20131443","journal-title":"Cancer Res"},{"key":"906_CR2","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1002\/(SICI)1096-9896(199711)183:3<311::AID-PATH917>3.0.CO;2-2","volume":"183","author":"Y Dong","year":"1997","unstructured":"Dong Y, Walsh MD, Cummings MC, Wright RG, Khoo SK, Parsons PG, McGuckin MA (1997) Expression of MUC1 and MUC2 mucins in epithelial ovarian tumours. J Pathol 183:311\u2013317","journal-title":"J Pathol"},{"key":"906_CR3","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1309\/1F99-BPDY-7DHH-9G97","volume":"118","author":"X Leroy","year":"2002","unstructured":"Leroy X, Zerimech F, Zini L, Copin MC, Buisine MP, Gosselin B, Aubert JP, Porchet N (2002) MUC1 expression is correlated with nuclear grade and tumor progression in pT1 renal clear cell carcinoma. Am J Clin Pathol 118:47\u201351","journal-title":"Am J Clin Pathol"},{"key":"906_CR4","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1016\/0016-5085(94)90592-4","volume":"106","author":"S Nakamori","year":"1994","unstructured":"Nakamori S, Ota DM, Cleary KR, Shirotani K, Irimura T (1994) MUC1 mucin expression as a marker of progression and metastasis of human colorectal carcinoma. Gastroenterology 106:353\u2013361","journal-title":"Gastroenterology"},{"key":"906_CR5","doi-asserted-by":"crossref","first-page":"588","DOI":"10.1007\/PL00006677","volume":"48","author":"B Acres","year":"2000","unstructured":"Acres B, Apostolopoulos V, Balloul JM, Wreschner D, Xing PX, Ali-Hadji D, Bizouarne N, Kieny MP, McKenzie IF (2000) MUC1-specific immune responses in human MUC1 transgenic mice immunized with various human MUC1 vaccines. Cancer Immunol Immunother 48:588\u2013594","journal-title":"Cancer Immunol Immunother"},{"key":"906_CR6","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1097\/00002371-199308000-00009","volume":"14","author":"RB Acres","year":"1993","unstructured":"Acres RB, Hareuveni M, Balloul JM, Kieny MP (1993) Vaccinia virus MUC1 immunization of mice: immune response and protection against the growth of murine tumors bearing the MUC1 antigen. J Immunother Emphasis Tumor Immunol 14:136\u2013143","journal-title":"J Immunother Emphasis Tumor Immunol"},{"key":"906_CR7","first-page":"5186","volume":"54","author":"V Apostolopoulos","year":"1994","unstructured":"Apostolopoulos V, Xing PX, McKenzie IF (1994) Murine immune response to cells transfected with human MUC1: immunization with cellular and synthetic antigens. Cancer Res 54:5186\u20135193","journal-title":"Cancer Res"},{"key":"906_CR8","first-page":"1693","volume":"6","author":"T Gilewski","year":"2000","unstructured":"Gilewski T, Adluri S, Ragupathi G, Zhang S, Yao TJ, Panageas K, Moynahan M, Houghton A, Norton L, Livingston PO (2000) Vaccination of high-risk breast cancer patients with mucin-1 (MUC1) keyhole limpet hemocyanin conjugate plus QS-21. Clin Cancer Res 6:1693\u20131701","journal-title":"Clin Cancer Res"},{"key":"906_CR9","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1006\/jsre.1996.0264","volume":"63","author":"JS Goydos","year":"1996","unstructured":"Goydos JS, Elder E, Whiteside TL, Finn OJ, Lotze MT (1996) A phase I trial of a synthetic mucin peptide vaccine. Induction of specific immune reactivity in patients with adenocarcinoma. J Surg Res 63:298\u2013304","journal-title":"J Surg Res"},{"key":"906_CR10","doi-asserted-by":"crossref","first-page":"2783","DOI":"10.1172\/JCI119825","volume":"100","author":"V Karanikas","year":"1997","unstructured":"Karanikas V, Hwang LA, Pearson J, Ong CS, Apostolopoulos V, Vaughan H, Xing PX, Jamieson G, Pietersz G, Tait B, Broadbent R, Thynne G, McKenzie IF (1997) Antibody and T cell responses of patients with adenocarcinoma immunized with mannan-MUC1 fusion protein. J Clin Invest 100:2783\u20132792","journal-title":"J Clin Invest"},{"key":"906_CR11","doi-asserted-by":"crossref","first-page":"869","DOI":"10.1158\/1078-0432.CCR-05-1574","volume":"12","author":"BE Loveland","year":"2006","unstructured":"Loveland BE, Zhao A, White S, Gan H, Hamilton K, Xing PX, Pietersz GA, Apostolopoulos V, Vaughan H, Karanikas V, Kyriakou P, McKenzie IF, Mitchell PL (2006) Mannan-MUC1-pulsed dendritic cell immunotherapy: a phase I trial in patients with adenocarcinoma. Clin Cancer Res 12:869\u2013877","journal-title":"Clin Cancer Res"},{"key":"906_CR12","first-page":"848s","volume":"7","author":"P Mukherjee","year":"2001","unstructured":"Mukherjee P, Ginardi AR, Tinder TL, Sterner CJ, Gendler SJ (2001) MUC1-specific cytotoxic T lymphocytes eradicate tumors when adoptively transferred in vivo. Clin Cancer Res 7:848s\u2013855s","journal-title":"Clin Cancer Res"},{"key":"906_CR13","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1097\/00002371-200301000-00006","volume":"26","author":"P Mukherjee","year":"2003","unstructured":"Mukherjee P, Madsen CS, Ginardi AR, Tinder TL, Jacobs F, Parker J, Agrawal B, Longenecker BM, Gendler SJ (2003) Mucin 1-specific immunotherapy in a mouse model of spontaneous breast cancer. J Immunother 26:47\u201362","journal-title":"J Immunother"},{"key":"906_CR14","doi-asserted-by":"crossref","first-page":"53","DOI":"10.3233\/BD-2004-20107","volume":"20","author":"P Mukherjee","year":"2004","unstructured":"Mukherjee P, Tinder TL, Basu GD, Pathangey LB, Chen L, Gendler SJ (2004) Therapeutic efficacy of MUC1-specific cytotoxic T lymphocytes and CD137 co-stimulation in a spontaneous breast cancer model. Breast Dis 20:53\u201363","journal-title":"Breast Dis"},{"key":"906_CR15","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1023\/A:1020360121451","volume":"7","author":"J Taylor-Papadimitriou","year":"2002","unstructured":"Taylor-Papadimitriou J, Burchell JM, Plunkett T, Graham R, Correa I, Miles D, Smith M (2002) MUC1 and the immunobiology of cancer. J Mammary Gland Biol Neoplasia 7:209\u2013221","journal-title":"J Mammary Gland Biol Neoplasia"},{"key":"906_CR16","doi-asserted-by":"crossref","first-page":"2740","DOI":"10.1016\/S0264-410X(98)00493-9","volume":"17","author":"HA Vaughan","year":"1999","unstructured":"Vaughan HA, Ho DW, Karanikas VA, Ong CS, Hwang LA, Pearson JM, McKenzie IF, Pietersz GA (1999) Induction of humoral and cellular responses in cynomolgus monkeys immunised with mannan-human MUC1 conjugates. Vaccine 17:2740\u20132752","journal-title":"Vaccine"},{"key":"906_CR17","doi-asserted-by":"crossref","first-page":"1980","DOI":"10.4049\/jimmunol.170.4.1980","volume":"170","author":"J Xia","year":"2003","unstructured":"Xia J, Tanaka Y, Koido S, Liu C, Mukherjee P, Gendler SJ, Gong J (2003) Prevention of spontaneous breast carcinoma by prophylactic vaccination with dendritic\/tumor fusion cells. J Immunol 170:1980\u20131986","journal-title":"J Immunol"},{"key":"906_CR18","first-page":"3315","volume":"56","author":"S Zhang","year":"1996","unstructured":"Zhang S, Graeber LA, Helling F, Ragupathi G, Adluri S, Lloyd KO, Livingston PO (1996) Augmenting the immunogenicity of synthetic MUC1 peptide vaccines in mice. Cancer Res 56:3315\u20133319","journal-title":"Cancer Res"},{"key":"906_CR19","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1038\/sj.gt.3301360","volume":"8","author":"SM Pupa","year":"2001","unstructured":"Pupa SM, Invernizzi AM, Forti S, Di Carlo E, Musiani P, Nanni P, Lollini PL, Meazza R, Ferrini S, Menard S (2001) Prevention of spontaneous neu-expressing mammary tumor development in mice transgenic for rat proto-neu by DNA vaccination. Gene Ther 8:75\u201379","journal-title":"Gene Ther"},{"key":"906_CR20","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1016\/j.imlet.2004.11.009","volume":"97","author":"J Holmgren","year":"2005","unstructured":"Holmgren J, Adamsson J, Anjuere F, Clemens J, Czerkinsky C, Eriksson K, Flach CF, George-Chandy A, Harandi AM, Lebens M, Lehner T, Lindblad M, Nygren E, Raghavan S, Sanchez J, Stanford M, Sun JB, Svennerholm AM, Tengvall S (2005) Mucosal adjuvants and anti-infection and anti-immunopathology vaccines based on cholera toxin, cholera toxin B subunit and CpG DNA. Immunol Lett 97:181\u2013188","journal-title":"Immunol Lett"},{"key":"906_CR21","doi-asserted-by":"crossref","first-page":"10795","DOI":"10.1073\/pnas.91.23.10795","volume":"91","author":"JB Sun","year":"1994","unstructured":"Sun JB, Holmgren J, Czerkinsky C (1994) Cholera toxin B subunit: an efficient transmucosal carrier-delivery system for induction of peripheral immunological tolerance. Proc Natl Acad Sci USA 91:10795\u201310799","journal-title":"Proc Natl Acad Sci USA"},{"key":"906_CR22","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1107\/S0907444900016814","volume":"57","author":"E Fan","year":"2001","unstructured":"Fan E, Merritt EA, Zhang Z, Pickens JC, Roach C, Ahn M, Hol WG (2001) Exploration of the GM1 receptor-binding site of heat-labile enterotoxin and cholera toxin by phenyl-ring-containing galactose derivatives. Acta Crystallogr D Biol Crystallogr 57:201\u2013212","journal-title":"Acta Crystallogr D Biol Crystallogr"},{"key":"906_CR23","doi-asserted-by":"crossref","first-page":"745","DOI":"10.1111\/j.1365-2958.1994.tb00467.x","volume":"13","author":"EA Merritt","year":"1994","unstructured":"Merritt EA, Sixma TK, Kalk KH, van Zanten BA, Hol WG (1994) Galactose-binding site in Escherichia coli heat-labile enterotoxin (LT) and cholera toxin (CT). Mol Microbiol 13:745\u2013753","journal-title":"Mol Microbiol"},{"key":"906_CR24","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1038\/351371a0","volume":"351","author":"TK Sixma","year":"1991","unstructured":"Sixma TK, Pronk SE, Kalk KH, Wartna ES, van Zanten BA, Witholt B, Hol WG (1991) Crystal structure of a cholera toxin-related heat-labile enterotoxin from E. coli. Nature 351:371\u2013377","journal-title":"Nature"},{"key":"906_CR25","doi-asserted-by":"crossref","first-page":"5716","DOI":"10.1128\/IAI.69.9.5716-5725.2001","volume":"69","author":"A George-Chandy","year":"2001","unstructured":"George-Chandy A, Eriksson K, Lebens M, Nordstrom I, Schon E, Holmgren J (2001) Cholera toxin B subunit as a carrier molecule promotes antigen presentation and increases CD40 and CD86 expression on antigen-presenting cells. Infect Immun 69:5716\u20135725","journal-title":"Infect Immun"},{"key":"906_CR26","first-page":"315","volume":"58","author":"GJ Rowse","year":"1998","unstructured":"Rowse GJ, Tempero RM, VanLith ML, Hollingsworth MA, Gendler SJ (1998) Tolerance and immunity to MUC1 in a human MUC1 transgenic murine model. Cancer Res 58:315\u2013321","journal-title":"Cancer Res"},{"key":"906_CR27","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1084\/jem.185.3.415","volume":"185","author":"M Marinaro","year":"1997","unstructured":"Marinaro M, Boyaka PN, Finkelman FD, Kiyono H, Jackson RJ, Jirillo E, McGhee JR (1997) Oral but not parenteral interleukin (IL)-12 redirects T helper 2 (Th2)-type responses to an oral vaccine without altering mucosal IgA responses. J Exp Med 185:415\u2013427","journal-title":"J Exp Med"},{"key":"906_CR28","doi-asserted-by":"crossref","unstructured":"Price MR, Rye PD, Petrakou E, Murray A, Brady K, Imai S, Haga S, Kiyozuka Y, Schol D, Meulenbroek MF, Snijdewint FG, von Mensdorff-Pouilly S, Verstraeten RA, Kenemans P, Blockzjil A, Nilsson K, Nilsson O, Reddish M, Suresh MR, Koganty RR, Fortier S, Baronic L, Berg A, Longenecker MB, Hilgers J et al (1998) Summary report on the ISOBM TD-4 Workshop: analysis of 56 monoclonal antibodies against the MUC1 mucin. San Diego, CA, USA, 17\u201323 November 1996. Tumour Biol 19(Suppl 1):1\u201320","DOI":"10.1159\/000056500"},{"issue":"Pt 3","key":"906_CR29","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1038\/icb.1989.29","volume":"67","author":"PX Xing","year":"1989","unstructured":"Xing PX, Tjandra JJ, Stacker SA, Teh JG, Thompson CH, McLaughlin PJ, McKenzie IF (1989) Monoclonal antibodies reactive with mucin expressed in breast cancer. Immunol Cell Biol 67(Pt 3):183\u2013195","journal-title":"Immunol Cell Biol"},{"key":"906_CR30","doi-asserted-by":"crossref","first-page":"5047","DOI":"10.1016\/j.vaccine.2006.03.045","volume":"24","author":"N Matoba","year":"2006","unstructured":"Matoba N, Geyer BC, Kilbourne J, Alfsen A, Bomsel M, Mor TS (2006) Humoral immune responses by prime-boost heterologous route immunizations with CTB-MPR(649\u2013684), a mucosal subunit HIV\/AIDS vaccine candidate. Vaccine 24:5047\u20135055","journal-title":"Vaccine"},{"key":"906_CR31","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1016\/S0167-5699(99)01523-6","volume":"20","author":"R Rappuoli","year":"1999","unstructured":"Rappuoli R, Pizza M, Douce G, Dougan G (1999) Structure and mucosal adjuvanticity of cholera and Escherichia coli heat-labile enterotoxins. Immunol Today 20:493\u2013500","journal-title":"Immunol Today"},{"key":"906_CR32","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1016\/S0167-5699(98)01397-8","volume":"20","author":"NA Williams","year":"1999","unstructured":"Williams NA, Hirst TR, Nashar TO (1999) Immune modulation by the cholera-like enterotoxins: from adjuvant to therapeutic. Immunol Today 20:95\u2013101","journal-title":"Immunol Today"},{"key":"906_CR33","doi-asserted-by":"crossref","first-page":"3205","DOI":"10.1002\/eji.200324135","volume":"33","author":"YI Kawamura","year":"2003","unstructured":"Kawamura YI, Kawashima R, Shirai Y, Kato R, Hamabata T, Yamamoto M, Furukawa K, Fujihashi K, McGhee JR, Hayashi H, Dohi T (2003) Cholera toxin activates dendritic cells through dependence on GM1-ganglioside which is mediated by NF-kappaB translocation. Eur J Immunol 33:3205\u20133212","journal-title":"Eur J Immunol"},{"key":"906_CR34","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1111\/j.0105-2896.2004.00148.x","volume":"199","author":"DM Klinman","year":"2004","unstructured":"Klinman DM, Currie D, Gursel I, Verthelyi D (2004) Use of CpG oligodeoxynucleotides as immune adjuvants. Immunol Rev 199:201\u2013216","journal-title":"Immunol Rev"},{"key":"906_CR35","first-page":"2693","volume":"9","author":"J Baines","year":"2003","unstructured":"Baines J, Celis E (2003) Immune-mediated tumor regression induced by CpG-containing oligodeoxynucleotides. Clin Cancer Res 9:2693\u20132700","journal-title":"Clin Cancer Res"},{"key":"906_CR36","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1002\/ijc.1286","volume":"93","author":"FG Snijdewint","year":"2001","unstructured":"Snijdewint FG, von Mensdorff-Pouilly S, Karuntu-Wanamarta AH, Verstraeten AA, Livingston PO, Hilgers J, Kenemans P (2001) Antibody-dependent cell-mediated cytotoxicity can be induced by MUC1 peptide vaccination of breast cancer patients. Int J Cancer 93:97\u2013106","journal-title":"Int J Cancer"},{"key":"906_CR37","doi-asserted-by":"crossref","first-page":"574","DOI":"10.1200\/JCO.2000.18.3.574","volume":"18","author":"S Mensdorff-Pouilly von","year":"2000","unstructured":"von Mensdorff-Pouilly S, Verstraeten AA, Kenemans P, Snijdewint FG, Kok A, Van Kamp GJ, Paul MA, Van Diest PJ, Meijer S, Hilgers J (2000) Survival in early breast cancer patients is favorably influenced by a natural humoral immune response to polymorphic epithelial mucin. J Clin Oncol 18:574\u2013583","journal-title":"J Clin Oncol"}],"container-title":["Cancer Immunology, Immunotherapy"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00262-010-0906-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00262-010-0906-1\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00262-010-0906-1","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,5,24]],"date-time":"2019-05-24T16:33:25Z","timestamp":1558715605000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00262-010-0906-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,9,8]]},"references-count":37,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2010,12]]}},"alternative-id":["906"],"URL":"https:\/\/doi.org\/10.1007\/s00262-010-0906-1","relation":{},"ISSN":["0340-7004","1432-0851"],"issn-type":[{"value":"0340-7004","type":"print"},{"value":"1432-0851","type":"electronic"}],"subject":[],"published":{"date-parts":[[2010,9,8]]}}}